CD14 and Crohn disease: We, and others, have shown that CD14+CD16+, but not CD14dimCD16+, monocytes are markedly enhanced at sites of inflammation in chronic autoimmune disorders such as RA and Crohn’s diseases (Fig. 2B) [14].